stockrow
Friday 6 November 2026
Export CBT’s income statement to Excel — free account
Cabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- +79.4%
- Free cash flow
- −51.7%
- Total debt
- +10.8%
Quarter to September 2026, against a year earlier
71.14
1.83
−2.51%
Follow CBT
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 5 | 6 |
+8 more TTM periods Free account |
| 12.20% | 11.00% | 17.21% | 18.93% | ||
| 5.41% | 4.81% | 7.34% | 8.30% | ||
ROIC |
10.77% | 11.18% | 12.85% | 14.17% | |
Return on Tangible Assets |
8.00% | 8.29% | 12.65% | 13.29% | |
Average Days of Receivables |
78.09 | 73.42 | 67.08 | 62.33 | |
Free Cash Flow per Share |
4.16 | 5.97 | 8.31 | 7.61 | |
Free Cash Flow |
214.00 | 308.00 | 432.00 | 401.00 | |
Capital Expenditures |
(207.00) | (189.00) | (239.00) | (266.00) | |
| Other line items | |||||
Cash ROIC |
6.53% | 9.46% | 13.34% | 13.00% | |
Accounts Receivable Turnover |
5.09 | 5.12 | 5.12 | 5.58 | |
Accounts Payable Turnover |
4.30 | 4.44 | 4.58 | 4.58 | |
Inventory Turnover |
5.40 | 5.12 | 5.06 | 5.18 | |
Average Days of Payables |
89.04 | 87.06 | 81.14 | 77.99 | |
Days of Inventory on Hand |
72.63 | 73.55 | 70.83 | 68.23 | |
Tax Rate |
(0.41) | (0.46) | (0.37) | (0.36) | |
Research and Development Expense of Revenue |
1.44% | 1.51% | 1.59% | 1.61% | |
Selling, General and Administrative Expense of Revenue |
7.43% | 7.62% | 7.44% | 7.29% | |
Share Based Compensation of Revenue |
0.00% | 0.50% | 0.48% | 0.53% | |
Interest Coverage |
6.36 | 6.66 | 7.49 | 7.83 | |
Operating CF/Net income |
1.99 | 2.64 | 2.38 | 2.17 | |
Depreciation/Fixed assets |
0.11 | 0.10 | 0.10 | 0.09 | |
Capex/Depreciation |
(1.08) | (1.05) | (1.41) | (1.68) | |
Revenue per Share |
72.70 | 70.43 | 68.75 | 68.44 | |
Operating CF per Share |
8.17 | 9.63 | 12.90 | 12.66 | |
Capex per Share |
(4.02) | (3.66) | (4.60) | (5.05) | |
Capex to Sales |
0.06 | 0.05 | 0.07 | 0.07 |
Columns are period end dates · fundamentals updated 5 Nov 2026